Autonomic hyper-reflexia--suppression with alpha-adrenergic blocking agents.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D002395:Catecholamines / Q000652:urine; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D008297:Male; D010264:Paraplegia / Q000150:complications; D010643:Phenoxybenzamine / Q000627:therapeutic use*; D010646:Phentolamine / Q000627:therapeutic use*; D011782:Quadriplegia / Q000150:complications; D012021:Reflex, Abnormal / Q000188:drug therapy* / Q000209:etiology; D014642:Vanilmandelic Acid / Q000652:urine
D000317:Adrenergic alpha-Antagonists; D002395:Catecholamines; D010643:Phenoxybenzamine; D014642:Vanilmandelic Acid; D010646:Phentolamine